Intermittent fasting improves metabolic outcomes in metabolic syndrome: a systematic review and meta-analysis with GRADE evaluation
Song Q, Almutairi ASH, Almutairi MFA, Jamilian P, Abu-Zaid A
Frontiers in nutrition · 1 cita
Cómo se estudió
- Diseño
- Revisión sistemática (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
Según la declaración de financiación del texto completo.
Publicación
- Publicado
- 2025-12-11 · Front Nutr · vol. 12 · pág. 1664811
- Editorial
- Frontiers Media
- Citado
- 3 citas · más que el 62% de estudios similares · 0.6× el promedio de su campo
- Referencias
- 32 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Dietary Effects on Health · Diabetes, Cardiovascular Risks, and Lipoproteins · Enhanced Recovery After Surgery
- Palabras clave
- intermittent fasting, metabolic syndrome, glycemic control, insulin resistance, HOMA-IR, lipid profile, LDL cholesterol, HDL cholesterol, interleukin-6, inflammatory markers, fasting blood glucose, HbA1c, dietary intervention, obesity, type 2 diabetes risk, cardiovascular risk factors, quality of evidence, GRADE, risk of bias, heterogeneity
5 autores
- Qian Song🇨🇳Tianjin University; Tianjin Hospital
- Alaa Sultan H. Almutairi🇧🇭Arabian Gulf University
- Manal Fehaid A. Almutairi🇧🇭Arabian Gulf University
- Parmida Jamilian🇬🇧 · autor de correspondenciaKeele University
- Ahmed Abu‐Zaid🇸🇦 · autor de correspondenciaAlfaisal University
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Previous studies have demonstrated that intermittent fasting (IF) has garnered scientific attention and gained recognition for its beneficial effects on metabolic outcomes. However, the results are inconsistent. Accordingly, this systematic review and meta-analysis aimed to evaluate the effect of fasting on glycemic control, lipid profile, and inflammatory markers.
Methods
Databases such as PubMed, Embase, Cochrane, Scopus, and Web of Science were used to retrieve relevant studies published until September 2025. The quality of the included studies was evaluated using the Cochrane Risk-of-Bias 2 (RoB2) tool. Moreover, the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach was employed to evaluate the quality of evidence.
Results
A total of 10 studies, involving 701 individuals, were included in the current meta-analysis. The combined effect of various types of fasting significantly reduced fasting blood sugar (FBS) [standard mean difference (SMD) = -0.51; 95% confidence interval (CI): -0.81, -0.20; p = 0.001], insulin (SMD = -0.27; 95% CI: -0.52, -0.03; p = 0.027) and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) (SMD = -0.39; 95% CI: -0.65, -0.12; p = 0.004), and HbA1c (SMD = -0.25; 95% CI: -0.49, -0.02; p = 0.034) levels. Moreover, the regimen successfully exerted its beneficial effect on low-density lipoprotein cholesterol (LDL-C) (SMD = -0.34; 95% CI: -0.53, -0.14; p = 0.001) and interleukin-6 (IL-6) (SMD = -0.30; 95% CI: -0.57, -0.03; p = 0.029) levels as well. The sensitivity analysis indicated that excluding any single study had no effect on the overall effect size (ES) for FBS, blood sugar (BS), HOMA-IR, LDL-C, and high-density lipoprotein cholesterol (HDL-C). Moreover, the results of the GRADE approach scored high quality of evidence for FBS, insulin, HOMA-IR, HbA1c, total cholesterol (TC), LDL-C, and IL-6, which suggests the robustness of the results. No evidence of publication bias was detected using Egger's and Begg's test (p > 0.05).
Conclusion
The findings suggest that intermittent fasting may have favorable effects on the metabolic panel, specifically, FBS, insulin, HOMA-IR, (HbA1c), LDL-C, and IL-6 levels.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.